How 23andMe went from a $6 billion valuation ...

Up next

Teflon Son? How Softbank CEO Masayoshi Son’s legend keeps growing

On today’s episode, host Josh Christensen is joined by ‘Fast Company’ associate editor David Salazar to help break down the latest news in the world of business and innovation, including the fallout from DeepSeek’s LLM launch, the backtracked federal funding freeze, and the risin ... Show more

. 1h 0min

Police departments are embracing AI-enhanced surveillance technology to stop crime

Police departments across the country are embracing AI-enhanced surveillance technology in the name of stopping crime. One prominent security firm called Flock Safety is leading the effort and profiting off our fears. Fast Company Senior Writer Ainsley Harris joined Yaz and Josh ... Show more

. 54min 4sec

Recommended Episodes

23andMe's Fatal Flaw | Defying Gravity? | 2

Business Wars

Plagued by low sales of its genetic tests, 23andMe adopts a bold new plan: slash prices and enter the pharmaceutical industry. But with investors nervous, can CEO Anne Wojcicki keep the show going long enough to make her DNA dream pay off?Be the first to know about Wondery’s newe ... Show more

. 39min 17sec

20VC: 23andMe's Anne Wojcicki on How To Approach Trust in Business and Personal Relationships, Leadership Lessons from Sheryl Sandberg and Reflections on How The Best Founders Manage Their Boards

The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch

Anne Wojcicki is the Founder & CEO @ 23andme, offering DNA testing with the most comprehensive ancestry breakdown, personalized health insights, and more. To date, A ...

. 41min 13sec

23andMe's Fatal Flaw | Guess Who’s Back | 3

Business Wars

Just when it looked like 23andMe was selling to Regeneron Pharmaceuticals, founder Anne Wojcicki placed a bid through her new nonprofit in an attempt to win it back at the eleventh hour. Lila MacLellan, Senior Writer at Fortune, joins David to discuss Wojcicki’s leadership style, ... Show more

. 37min 55sec

CEO Series: 23andMe’s Anne Wojcicki on Scientific Breakthroughs and Public Trust

HBR IdeaCast

Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more about their own genetics, enabling them to pursue more personalized medical care, and ... Show more

. 23min 55sec